Michael & Susan Dell Foundation Diversified Active

CIK: 0001599858 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $96,389 (100.0% shares, 0.0% debt)

Holdings (7)

CCI CROWN CASTLE INTL CORP NEW 34.0%

Value ($000) $32,792 Shares 323,300 Est. Cost $50.35 Unrealized +20.5%

— AETNA INC NEW 17.8%

Value ($000) $17,194 Shares 140,786 Est. Cost $68.59 Unrealized —

CFG CITIZENS FINL GROUP INC 15.4%

Value ($000) $14,885 Shares 745,000 Est. Cost $17.09 Unrealized -9.5%

JPM JPMORGAN CHASE & CO 15.3%

Value ($000) $14,780 Shares 237,853 Est. Cost $40.19 Unrealized +20.2%

— INTREXON CORP 11.1%

Value ($000) $10,653 Shares 432,878 Est. Cost $25.55 Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 5.9%

Value ($000) $5,719 Shares 39,500 Est. Cost $132.58 Unrealized +7.8%

— ZIOPHARM ONCOLOGY INC 0.4%

Value ($000) $366 Shares 66,749 Est. Cost $12.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CCI	CROWN CASTLE INTL CORP NEW	323,300	$32,792	34.0%	$50.35	+20.5%	COM	22822V101
—	AETNA INC NEW	140,786	$17,194	17.8%	$68.59	—	COM	00817Y108
CFG	CITIZENS FINL GROUP INC	745,000	$14,885	15.4%	$17.09	-9.5%	COM	174610105
JPM	JPMORGAN CHASE & CO	237,853	$14,780	15.3%	$40.19	+20.2%	COM	46625H100
—	INTREXON CORP	432,878	$10,653	11.1%	$25.55	—	COM	46122T102
BRK/B	BERKSHIRE HATHAWAY INC DEL	39,500	$5,719	5.9%	$132.58	+7.8%	CL B NEW	084670702
—	ZIOPHARM ONCOLOGY INC	66,749	$366	0.4%	$12.00	—	COM	98973P101